Eagle Capital Growth Fund Inc (GRF AMEX) stock market data APIs
$10.4265
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
Eagle Capital Growth Fund Inc Financial Data Overview
Price chart is built with
Anychart
Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P 500 Index. It was previously known as NAIC Growth Fund, Inc. Eagle Capital Growth Fund, Inc. was formed on April 11, 1989 and is domiciled in the United States.
Prev. Close
10.4265
Open
10.4347
High
10.5207
Low
10.3447
52 wk Range
9.4079-11.85
Market Cap
41 345 K
P/E Ratio
10.42
Shares Outstanding
3 968 K
Revenue
902 K
EPS
0.49
Dividends (Yield)
0.0815
Beta
0.232
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eagle Capital Growth Fund Inc data using free add-ons & libraries
Get Eagle Capital Growth Fund Inc Fundamental Data
Eagle Capital Growth Fund Inc Fundamental data includes:
- Net Revenue: 902 K
- EBITDA:
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Eagle Capital Growth Fund Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eagle Capital Growth Fund Inc News
New
Grifols (BME:GRF) Starts Phase 3 Trials As Undervalued Narrative Faces A Fresh Test
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Grifols (BME:GRF) has started dosing patients in two Phas...
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
Grifols, S.A. One trial, SIGMA, will evaluate Grifols' intravenous immunoglobulin (Ig) GAMUNEX®-C (immune globulin injection [human], 10% caprylate chromatography purified) plus standard medical tre...
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Grifols, S.A. The new fibrinogen concentrate, approved in the U.S. for acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, is now available in the U.S. FES...
How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Analysts have trimmed their...
Get Eagle Capital Growth Fund Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
